FDA NDC Directory · JSON-LD · Markdown

DARIFENACIN

NDC 62332-224 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207681
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDARIFENACIN HYDROBROMIDE (15 mg/1)
Marketing started20171212
Package count4

External sources

Source: openFDA. Public-domain (CC0).